News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.

‘Collateral’ lethality may offer new therapeutic approach for cancers of the pancreas, stomach and colon

Heard of collateral lethality? It’s a therapeutic strategy that uses gene deletions with no direct role in the tumor progression. A recent study published in Science Daily shows how scientists discovered that this process can be used in novel therapy approaches for gastric cancer.

Read Source